| 2018 | 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
| Breast Cancer Research and Treatment |
| 2019 | A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients | BREAST CANCER RESEARCH AND TREATMENT |
| 2015 | Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2010 | Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | Analysis of phyllodes tumor recurrence according to the histologic grade | BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens | BREAST CANCER RESEARCH AND TREATMENT |
| 1997 | Breast conserving therapy in stage I & II breast cancer in Korea | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Cardiac toxicities of lapatinib in patients with breast cancer and other HER2-positive cancers: a meta-analysis | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Chemotherapy-induced irreversible alopecia in early breast cancer patients | BREAST CANCER RESEARCH AND TREATMENT |
| 2018 | Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy. | BREAST CANCER RESEARCH AND TREATMENT |
| 2019 | Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study | Breast Cancer Research and Treatment |
| 2021 | Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
| BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib | BREAST CANCER RESEARCH AND TREATMENT |
| 2023 | Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12) | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy | BREAST CANCER RESEARCH AND TREATMENT |
| 2018 | Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis. | BREAST CANCER RESEARCH AND TREATMENT |
| 2009 | Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population | BREAST CANCER RESEARCH AND TREATMENT |
| 2009 | Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). | BREAST CANCER RESEARCH AND TREATMENT |
| 2005 | Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | BREAST CANCER RESEARCH AND TREATMENT |
| 2012 | Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study | BREAST CANCER RESEARCH AND TREATMENT |
| 2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society | BREAST CANCER RESEARCH AND TREATMENT |
| 2015 | Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | Differential expression of immune-related markers in breast cancer by molecular phenotypes | BREAST CANCER RESEARCH AND TREATMENT |
| 2015 | Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy? | BREAST CANCER RESEARCH AND TREATMENT |
| 2023 | Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2011 | Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers. | BREAST CANCER RESEARCH AND TREATMENT |
| 2016 | Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants | BREAST CANCER RESEARCH AND TREATMENT |
| 2016 | Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma | BREAST CANCER RESEARCH AND TREATMENT |
| 2003 | Expression of Estrogen Receptor-β in Normal Mammary and Tumor Tissues: is it Protective in Breast Carcinogenesis? | BREAST CANCER RESEARCH AND TREATMENT |
| 2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2012 | Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers | BREAST CANCER RESEARCH AND TREATMENT |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2009 | Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them | BREAST CANCER RESEARCH AND TREATMENT |
| 2014 | Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04) | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and Older | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen? | BREAST CANCER RESEARCH AND TREATMENT |
| 2023 | Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41 | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. | BREAST CANCER RESEARCH AND TREATMENT |
| 2018 | Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08). | BREAST CANCER RESEARCH AND TREATMENT |
| 2008 | Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12) | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy | BREAST CANCER RESEARCH AND TREATMENT |
| 1997 | P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 1996 | P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 1998 | Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value? | BREAST CANCER RESEARCH AND TREATMENT |
| 2019 | Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Radiation-related heart disease after breast cancer radiation therapy in Korean women | BREAST CANCER RESEARCH AND TREATMENT |
| 2017 | Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02) | BREAST CANCER RESEARCH AND TREATMENT |
| 2023 | Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea | BREAST CANCER RESEARCH AND TREATMENT |
| 2016 | Resting heart rate as a prognostic factor for mortality in patients with breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2019 | Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis | BREAST CANCER RESEARCH AND TREATMENT |
